SynthesisMedicina oral, patologia oral y cirugia bucal2026
Efficacy of topical application of zinc compounds for oral mucosal diseases: A systematic review and meta-analysis.
Synthesis in Medicina oral, patologia oral y cirugia bucal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- The Route of Administration Determines the Efficacy of Zinc in Preventing Radiation-Induced Oral Mucositis: A Systematic Review and Meta-Analysis.Current oncology (Toronto, Ont.) · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundZinc has been used as a topical therapeutic agent for the management of various oral and dermatological conditions. The purpose of this systematic review was to evaluate the effectiveness of topical zinc therapy in the prevention and treatment of oral mucosal diseases. MATERIAL AND
methodsA comprehensive literature search across four databases identified studies evaluating the effects of topical zinc therapy on oral mucosal diseases. Two independent reviewers evaluated the identified studies, extracting relevant data. Risk of bias assessment and meta-analysis were performed for randomized controlled trials (RCTs).
resultsThis systematic review included 14 studies: eight on oral mucositis, three on recurrent aphthous stomatitis (RAS), two on oral lichen planus (OLP), and one on herpes simplex virus (HSV) infection. Among them, seven studies on oral mucositis, two on RAS, and two on OLP were RCTs. The oral mucositis studies demonstrated that topical zinc therapy significantly alleviated cancer therapy-induced oral mucositis, with meta-analysis confirming significant improvement at weeks 2, 3, and 4 compared with control treatments. For RAS, topical zinc therapy reduced pain intensity and ulcer size although significant differences between treatment and control groups were observed in only one RCT. For OLP, two RCTs reported symptom improvement although treatment outcomes varied. Additionally, a case series has suggested the potential benefit of topical zinc in mitigating HSV recurrence.
conclusionsTopical zinc therapy has promising efficacy in managing oral mucosal diseases, particularly in cancer therapy-induced oral mucositis. However, evidence for other conditions remains limited. Further comprehensive RCTs are needed to establish its effectiveness across various oral mucosal diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.